171 related articles for article (PubMed ID: 16425071)
1. Outcome and treatment strategy for mid- and lower-thoracic esophageal cancer recurring locally in the lymph nodes of the neck.
Motoyama S; Kitamura M; Saito R; Maruyama K; Okuyama M; Ogawa J
World J Surg; 2006 Feb; 30(2):191-8. PubMed ID: 16425071
[TBL] [Abstract][Full Text] [Related]
2. Treatment outcome and prognosis of patients with lymph node recurrence of thoracic esophageal squamous cell carcinoma after curative resection.
Kosuga T; Shiozaki A; Fujiwara H; Ichikawa D; Okamoto K; Komatsu S; Otsuji E
World J Surg; 2011 Apr; 35(4):798-804. PubMed ID: 21312037
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis and surgical outcomes for primary malignant melanoma of the esophagus: a single-center experience.
Wang S; Tachimori Y; Hokamura N; Igaki H; Kishino T; Kushima R
Ann Thorac Surg; 2013 Sep; 96(3):1002-6. PubMed ID: 23810175
[TBL] [Abstract][Full Text] [Related]
4. A strategy for supraclavicular lymph node dissection using recurrent laryngeal nerve lymph node status in thoracic esophageal squamous cell carcinoma.
Taniyama Y; Nakamura T; Mitamura A; Teshima J; Katsura K; Abe S; Nakano T; Kamei T; Miyata G; Ouchi N
Ann Thorac Surg; 2013 Jun; 95(6):1930-7. PubMed ID: 23642437
[TBL] [Abstract][Full Text] [Related]
5. Patterns of lymph node metastasis and survival for upper esophageal squamous cell carcinoma.
Jang HJ; Lee HS; Kim MS; Lee JM; Zo JI
Ann Thorac Surg; 2011 Sep; 92(3):1091-7. PubMed ID: 21704967
[TBL] [Abstract][Full Text] [Related]
6. Node status in transmural esophageal adenocarcinoma and outcome after en bloc esophagectomy.
Nigro JJ; DeMeester SR; Hagen JA; DeMeester TR; Peters JH; Kiyabu M; Campos GM; Oberg S; Gastal O; Crookes PF; Bremner CG
J Thorac Cardiovasc Surg; 1999 May; 117(5):960-8. PubMed ID: 10220691
[TBL] [Abstract][Full Text] [Related]
7. Association of the primary tumor location with the site of tumor recurrence after curative resection of thoracic esophageal carcinoma.
Doki Y; Ishikawa O; Takachi K; Miyashiro I; Sasaki Y; Ohigashi H; Murata K; Yamada T; Noura S; Eguchi H; Kabuto T; Imaoka S
World J Surg; 2005 Jun; 29(6):700-7. PubMed ID: 16078126
[TBL] [Abstract][Full Text] [Related]
8. Recurrence pattern of squamous cell carcinoma of the thoracic esophagus after extended radical esophagectomy with three-field lymphadenectomy.
Nakagawa S; Kanda T; Kosugi S; Ohashi M; Suzuki T; Hatakeyama K
J Am Coll Surg; 2004 Feb; 198(2):205-11. PubMed ID: 14759776
[TBL] [Abstract][Full Text] [Related]
9. Isolated local recurrence or solitary solid organ metastasis after esophagectomy for cancer is not the end of the road.
Depypere L; Lerut T; Moons J; Coosemans W; Decker G; Van Veer H; De Leyn P; Nafteux P
Dis Esophagus; 2017 Jan; 30(1):1-8. PubMed ID: 27704661
[TBL] [Abstract][Full Text] [Related]
10. Cervical lymphadenectomy is beneficial for patients with carcinoma of the upper and mid-thoracic esophagus.
Nakagawa S; Nishimaki T; Kosugi S; Ohashi M; Kanda T; Hatakeyama K
Dis Esophagus; 2003; 16(1):4-8. PubMed ID: 12581247
[TBL] [Abstract][Full Text] [Related]
11. Survival in Patients With Esophageal Adenocarcinoma Undergoing Trimodality Therapy Is Independent of Regional Lymph Node Location.
Sepesi B; Schmidt HE; Lada M; Correa AM; Walsh GL; Mehran RJ; Rice DC; Roth JA; Vaporciyan AA; Ajani JA; Watson TJ; Swisher SG; Low DE; Hofstetter WL
Ann Thorac Surg; 2016 Mar; 101(3):1075-80; Discussion 1080-1. PubMed ID: 26680311
[TBL] [Abstract][Full Text] [Related]
12. Outcome of histologically node-negative esophageal squamous cell carcinoma.
Tabira Y; Yasunaga M; Sakaguchi T; Yamaguchi Y; Okuma T; Kawasuji M
World J Surg; 2002 Dec; 26(12):1446-51. PubMed ID: 12297913
[TBL] [Abstract][Full Text] [Related]
13. A second malignancy is the major cause of death among thoracic squamous cell esophageal cancer patients negative for lymph node involvement.
Sato Y; Motoyama S; Maruyama K; Okuyama M; Ogawa J
J Am Coll Surg; 2005 Aug; 201(2):188-93. PubMed ID: 16038814
[TBL] [Abstract][Full Text] [Related]
14. Two-step three-field lymph node dissection is beneficial for thoracic esophageal carcinoma.
Noguchi T; Wada S; Takeno S; Hashimoto T; Moriyama H; Uchida Y
Dis Esophagus; 2004; 17(1):27-31. PubMed ID: 15209737
[TBL] [Abstract][Full Text] [Related]
15. Total number of resected lymph nodes predicts survival in esophageal cancer.
Altorki NK; Zhou XK; Stiles B; Port JL; Paul S; Lee PC; Mazumdar M
Ann Surg; 2008 Aug; 248(2):221-6. PubMed ID: 18650631
[TBL] [Abstract][Full Text] [Related]
16. Autopsy findings in patients after curative esophagectomy for esophageal carcinoma.
Katayama A; Mafune K; Tanaka Y; Takubo K; Makuuchi M; Kaminishi M
J Am Coll Surg; 2003 Jun; 196(6):866-73. PubMed ID: 12788422
[TBL] [Abstract][Full Text] [Related]
17. [Recurrence patterns of esophageal cancer after Ivor-Lewis esophagectomy--a report of 196 cases].
Chen G; Wang Z; Liu XY; Liu FY
Ai Zheng; 2006 Jan; 25(1):96-9. PubMed ID: 16405760
[TBL] [Abstract][Full Text] [Related]
18. Pattern of lymph node metastases in patients with squamous cell carcinoma of the thoracic esophagus who underwent three-field lymphadenectomy.
Li H; Zhang Y; Cai H; Xiang J
Eur Surg Res; 2007; 39(1):1-6. PubMed ID: 17106199
[TBL] [Abstract][Full Text] [Related]
19. The impact of adjuvant therapies on patient survival and the recurrence patterns for resected stage IIa-IVa lower thoracic oesophageal squamous cell carcinoma.
Wang Y; Zhu L; Xia W; Wu L; Wang F
World J Surg Oncol; 2018 Nov; 16(1):216. PubMed ID: 30404621
[TBL] [Abstract][Full Text] [Related]
20. Can common hepatic artery lymph node dissection be safely omitted in surgery for clinical T1N0 thoracic esophageal squamous cell carcinoma?
Shim YM; Park JS; Lee M; Kim D; Kim K
Dis Esophagus; 2013 Apr; 26(3):272-5. PubMed ID: 22642487
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
